Sheng Zhengzuo, Liu Yang, Qin Caipeng, Liu Zhenhua, Yuan Yeqing, Hu FengZhan, Du Yiqing, Yin Huaqi, Qiu Xiaoyan, Xu Tao
Department of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Department of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing, China Peking University Center for Human Disease Genomics, Beijing, China.
J Clin Pathol. 2016 Jun;69(6):497-504. doi: 10.1136/jclinpath-2015-202881. Epub 2015 Oct 30.
To investigate if IgG can be expressed in clear cell renal cell carcinoma (cRCC) , and the expression of IgG is involved in the cancer progression. If IgG expression can serve as a potential target in cancer therapies and be used for judging the prognosis.
By immunohistochemistry, we detected IgG in cRCC tissues(75 cRCC tissues and75 adjacent normal kidney tissues). Immunofluorescence and Western blot was used to detect the IgG in cRCC cell lines (786-0, ACHN and CAKI-I). By RT-PCR, the functional transcript of IgG heavy chain was detected. Knockdown of IgG was to analyze the proliferation, migration and invasion ability by CCK8, Transwell and Matrigel and apoptosis in cRCC cell lines.
By immunohistochemistry, we found strong staining of IgG in 66 cases of 75 cRCC tissues and 63 cases of 75 adjacent normal kidney tissues. Immunofluorescence and Western blot was found IgG in cRCC cell lines. Knock-down IgG in cRCC cell lines resulted in significant inhibition of cell proliferation, migration and invasion, and the induction of apoptosis of the 786-0 cells. The immunohistochemistry analysis showed that high IgG expression significantly correlated with the poor differentiation and advanced stage of cRCC.
IgG was over expressed in cRCC and was involved in the proliferation, migration and invasion of cancer cells. IgG expression may serve as a potential target in cancer therapies and could be used for judging the prognosis.
研究免疫球蛋白G(IgG)在透明细胞肾细胞癌(cRCC)中是否表达,以及IgG的表达是否参与癌症进展。探讨IgG表达能否作为癌症治疗的潜在靶点并用于判断预后。
采用免疫组织化学方法检测cRCC组织(75例cRCC组织和75例癌旁正常肾组织)中的IgG。利用免疫荧光和蛋白质印迹法检测cRCC细胞系(786-0、ACHN和CAKI-I)中的IgG。通过逆转录聚合酶链反应(RT-PCR)检测IgG重链的功能性转录本。敲低IgG后,通过细胞计数试剂盒8(CCK8)、Transwell和基质胶实验分析cRCC细胞系的增殖、迁移和侵袭能力以及细胞凋亡情况。
免疫组织化学检测发现,75例cRCC组织中有66例IgG呈强染色,75例癌旁正常肾组织中有63例呈强染色。免疫荧光和蛋白质印迹法检测发现cRCC细胞系中有IgG表达。敲低cRCC细胞系中的IgG可显著抑制细胞增殖、迁移和侵袭,并诱导786-0细胞凋亡。免疫组织化学分析显示,IgG高表达与cRCC的低分化和晚期显著相关。
IgG在cRCC中过表达,并参与癌细胞的增殖、迁移和侵袭。IgG表达可能作为癌症治疗的潜在靶点,并可用于判断预后。